This article presents the results of a survey conducted to gain insight on the impact of the COVID-19 pandemic on biomanufacturing operations.
Paul W. Barone
Advertisement
Paul W. Barone, pbarone@mit.edu, is co-director, Biomanufacturing Program at MIT Center for Biomedical Innovation.
Articles by Paul W. Barone
Advertisement
Latest Updated Articles
The Impact of SARS-CoV-2 on Biomanufacturing OperationsPublished: August 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
2
Establishing Risk Assessments for AI in Bio-Manufacturing
3
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
4
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
5
